123 related articles for article (PubMed ID: 391517)
21. The influence of prostacyclin on coronary occlusion induced arrhythmia in cats.
Dix RK; Kelliher GJ; Jurkiewicz N; Lawrence T
Prostaglandins Med; 1979 Sep; 3(3):173-84. PubMed ID: 399533
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-II-stimulated release of thromboxane A2 and prostacyclin (PGI2) in isolated, perfused kidneys of spontaneously hypertensive rats.
Shibouta Y; Inada Y; Terashita Z; Nishikawa K; Kikuchi S; Shimamoto K
Biochem Pharmacol; 1979 Dec; 28(24):3601-9. PubMed ID: 394747
[No Abstract] [Full Text] [Related]
23. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
MacFadyen RJ; Tree M; Lever AF; Reid JL
Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
[TBL] [Abstract][Full Text] [Related]
24. Responses of mean arterial pressure to pressor agents and diuretics in renal hypertensive and salt hypertensive rats.
Nicholas TE
Br J Pharmacol; 1971 Jun; 42(2):179-92. PubMed ID: 4326321
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II/prostaglandin I2 interactions in spontaneously hypertensive rats.
Jackson EK; Herzer WA
Hypertension; 1993 Nov; 22(5):688-98. PubMed ID: 8225529
[TBL] [Abstract][Full Text] [Related]
26. Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs.
Starnes VA; Primm RK; Woosley RL; Oates JA; Hammon JW
J Cardiovasc Pharmacol; 1982; 4(5):765-9. PubMed ID: 6182407
[TBL] [Abstract][Full Text] [Related]
27. Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure.
Crofton JT; Share L; Brooks DP
J Hypertens; 1986 Jun; 4(3):307-12. PubMed ID: 3734447
[TBL] [Abstract][Full Text] [Related]
28. Increased renal vascular sensitivity to angiotensin II in hypertension is due to decreased response to prostaglandins.
Palmgren E; Widgren B; Aurell M; Herlitz H
J Hypertens; 2003 May; 21(5):969-76. PubMed ID: 12714872
[TBL] [Abstract][Full Text] [Related]
29. Vasodepressor effects of arachidonic acid and prostacyclin (PGI2) in hypertensive rats.
Dusting GJ; Di Nicolantonio R; Drysdale T; Doyle AE
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():315s-318s. PubMed ID: 6797776
[TBL] [Abstract][Full Text] [Related]
30. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.
Hyman AL; Kadowitz PJ
Circ Res; 1979 Sep; 45(3):404-9. PubMed ID: 110490
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man.
Warrington SJ; Smith PR; O'Grady J
Eur J Cardiol; 1980; 12(2):73-80. PubMed ID: 7002563
[TBL] [Abstract][Full Text] [Related]
34. Changes of mean arterial pressure of the rat resulting from intracerebroventricular injections of prostacyclin or 6-keto-prostaglandin F1 alpha.
Kenney NJ
Prostaglandins; 1983 Mar; 25(3):335-42. PubMed ID: 6346396
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats.
Lima CV; Paula RD; Resende FL; Khosla MC; Santos RA
Hypertension; 1997 Sep; 30(3 Pt 2):542-8. PubMed ID: 9322979
[TBL] [Abstract][Full Text] [Related]
36. In vivo and in vitro magnesium effects on aortic prostacyclin generation in DOCA-salt hypertensive rats.
Laurant P; Moussard C; Alber D; Henry JC; Berthelot A
Prostaglandins Leukot Essent Fatty Acids; 1992 Nov; 47(3):183-6. PubMed ID: 1475272
[TBL] [Abstract][Full Text] [Related]
37. Epoprostenol (prostacyclin,PGI2) increases apparent liver blood flow in man.
Hassan S; Pickles H
Prostaglandins Leukot Med; 1983 Apr; 10(4):449-54. PubMed ID: 6344102
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
Brown NJ; Ryder D; Gainer JV; Morrow JD; Nadeau J
J Pharmacol Exp Ther; 1996 Nov; 279(2):703-12. PubMed ID: 8930174
[TBL] [Abstract][Full Text] [Related]
39. The hemodynamic effects of prostacyclin infusions in normotensive and ACTH induced hypertensive conscious sheep.
Mason RT; Allen KJ; Coghlan JP; Denton DA; Fei DT; Graham WF; Stewart KW; Scoggins BA
Prostaglandins Leukot Med; 1984 Oct; 16(1):57-68. PubMed ID: 6096893
[TBL] [Abstract][Full Text] [Related]
40. Blood pressure and cardiac tissue responses to prostacyclin (PGI2) in various species.
Collins GA; MacLeod BA; Walker MJ
Can J Physiol Pharmacol; 1982 Feb; 60(2):134-9. PubMed ID: 6282426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
